Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study. Issue 10 (23rd July 2021)

• Record Type: Journal Article
• Authors: Paris, Sara; Inciardi, Riccardo M; Lombardi, Carlo Mario; Tomasoni, Daniela; Ameri, Pietro; Carubelli, Valentina; Agostoni, Piergiuseppe; Canale, Claudia; Carugo, Stefano; Danzi, Giambattista; Di Pasquale, Mattia; Sarullo, Filippo; La Rovere, Maria Teresa; Mortara, Andrea; Piepoli, Massimo; Porto, Italo; Sinagra, Gianfranco; Volterrani, Maurizio; Gnecchi, Massimiliano; Leonardi, Sergio; Merlo, Marco; Iorio, Annamaria; Giovinazzo, Stefano; Bellasi, Antonio; Zaccone, Gregorio; Camporotondo, Rita; Catagnano, Francesco; Dalla Vecchia, Laura; Maccagni, Gloria; Mapelli, Massimo; Margonato, Davide; Monzo, Luca; Nuzzi, Vincenzo; Pozzi, Andrea; Provenzale, Giovanni; Specchia, Claudia; Tedino, Chiara; Guazzi, Marco; Senni, Michele; Metra, Marco;
• Is Part Of: Europace. Volume 23:Issue 10(2021)
• Page Start: 1603
• Page End: 1611
• Publication Date: 2021-07-23
• Subjects: Coronavirus disease 2019 -- Severe acute respiratory syndrome coronavirus-2 infection -- Atrial fibrillation -- Outcome; Arrhythmia -- Treatment -- Periodicals; Cardiac pacing -- Periodicals; Catheter ablation -- Periodicals; Heart -- Physiology -- Periodicals; Electrophysiology -- Periodicals; 617.4120645
• DOI: 10.1093/europace/euab146
• Languages: English
• ISSNs: 1099-5129

Abstract

Abstract: Aims: To assess the clinical relevance of a history of atrial fibrillation (AF) in hospitalized patients with coronavirus disease 2019 (COVID-19). Methods and results: We enrolled 696 consecutive patients (mean age 67.4 ± 13.2 years, 69.7% males) admitted for COVID-19 in 13 Italian cardiology centres between 1 March and 9 April 2020. One hundred and six patients (15%) had a history of AF and the median hospitalization length was 14 days (interquartile range 9–24). Patients with a history of AF were older and with a higher burden of cardiovascular risk factors. Compared to patients without AF, they showed a higher rate of in-hospital death (38.7% vs. 20.8%; P < 0.001). History of AF was associated with an increased risk of death after adjustment for clinical confounders related to COVID-19 severity and cardiovascular comorbidities, including history of heart failure (HF) and increased plasma troponin [adjusted hazard ratio (HR): 1.73; 95% confidence interval (CI) 1.06–2.84; P = 0.029]. Patients with a history of AF also had more in-hospital clinical events including new-onset AF (36.8% vs. 7.9%; P < 0.001), acute HF (25.3% vs. 6.3%; P < 0.001), and multiorgan failure (13.9% vs. 5.8%; P = 0.010). The association between AF and worse outcome was not modified by previous or concomitant use of anticoagulants or steroid therapy ( P for interaction >0.05 for both) and was not related to stroke or bleeding events. Conclusion: Among hospitalized patients with COVID-19, a history of AF contributes to worse clinical course with a higher mortality and in-hospital events including new-onset AF, acute HF, and multiorgan failure. The mortality risk remains significant after adjustment for variables associated with COVID-19 severity and comorbidities.